Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on June 15, 2026

Jun. 15, 2026

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

Indeterminate GlobeNewswire

Jun. 15, 2026

XBiotech startet klinische Phase-II-Studie zur Bewertung von Vilamakitug bei der Behandlung der aktiven axialen Spondyloarthritis

Indeterminate GlobeNewswire

Jun. 15, 2026

XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active

Indeterminate GlobeNewswire

Jun. 15, 2026

BVI Expands Commitment to Ophthalmic Education with New Experience Hub in Europe

Indeterminate GlobeNewswire

Jun. 15, 2026

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Indeterminate GlobeNewswire

Jun. 15, 2026

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

Indeterminate GlobeNewswire

Jun. 15, 2026

Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec

Indeterminate GlobeNewswire

Jun. 15, 2026

Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes

Indeterminate GlobeNewswire

Jun. 15, 2026

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Indeterminate GlobeNewswire

Jun. 15, 2026

NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform

Indeterminate GlobeNewswire

Jun. 15, 2026

Sienna Announces June Dividend

Indeterminate GlobeNewswire

Jun. 15, 2026

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

Indeterminate GlobeNewswire

Jun. 15, 2026

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Indeterminate GlobeNewswire

Jun. 15, 2026

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Indeterminate GlobeNewswire

Jun. 15, 2026

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Indeterminate GlobeNewswire

Jun. 15, 2026

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

Indeterminate GlobeNewswire

Jun. 15, 2026

Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas

Indeterminate GlobeNewswire

Jun. 15, 2026

SpyGlass Pharma Appoints Shannon Treviño as General Counsel

Indeterminate GlobeNewswire

Jun. 15, 2026

KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 15, 2026

Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India

Indeterminate GlobeNewswire